Interim Analysis Of Phase 2 Clinical Trial In Onychomycosis (topical Lotion For Nail Fungus) Completed By NanoBio Corporation

NanoBio Corporation has announced that it has seen promising results from an interim analysis of its phase 2 study of NB-002, a topical lotion for onychomycosis (nail fungus). Although the details remain confidential, the results clearly justify completing the study, according to NanoBio scientists.

More: continued here

Filed under: Dermatology on April 2nd, 2008